Xiangyi Liu

机构：Xidian University, Peking University, Williams (United States), Wenzhou Medical University, Broomfield Hospital, First Affiliated Hospital of Wenzhou Medical University, Guangzhou Center for Disease Control and Prevention, Peking University Third Hospital, Scherrer (Switzerland), University of Houston, The University of Texas Health Science Center at Houston · ORCID：0000-0002-0598-9183

发表论文 56 篇 · 总被引 689 次 · h-index 13

代表论文

• Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review) (2024 · Molecular Medicine Reports · 被引 47)
• Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver (2022 · Drug Design Development and Therapy · 被引 37)
• Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo (2022 · Frontiers in Pharmacology · 被引 15)
• Diabetes Mellitus and Hyperlipidemia Status Among Hypertensive Patients in the Community and Influencing Factors Analysis of Blood Pressure Control (2025 · Journal of Clinical Hypertension · 被引 11)
• Effects of Acupuncture-Related Therapies in the Rehabilitation of Patients with Post-Stroke Aphasia—A Network Meta-Analysis of Randomized Controlled Trials (2022 · Brain Sciences · 被引 9)
• A Low-Channel-Mismatch ExG AFE Based on Orthogonal Nested-Chopper and Successive-Approximation Input Capacitance Calibration (2025 · IEEE Sensors Journal · 被引 7)